Sameer Zuberi

Dr. Sameer Zuberi is an Honorary Professor in Paediatric Neurology at the University of Glasgow's School of Health & Wellbeing. He specializes in epilepsy genetics, particularly in Dravet syndrome and SCN1A-related disorders. His research focuses on gene-disease associations, treatment outcomes, and improving the quality of life for patients and families affected by rare neurological conditions. Dr. Zuberi has contributed to international epilepsy classification efforts, including the ILAE Task Force on Nosology and Definitions. He leads projects on epilepsy precision medicine, genetic epilepsy phenotyping, and the social impact of neurodevelopmental disorders.

His work includes studies on caregiver burden in Dravet syndrome, the burden of illness in Lennox-Gastaut syndrome, and the efficacy of treatments such as fenfluramine. He has also pioneered research on genomic modifiers in 'monogenic' conditions like Dravet syndrome, highlighting the complexity of genetic influences.

Dr. Zuberi collaborates with multidisciplinary teams to advance understanding of neurodevelopmental outcomes, psychosocial impacts, and translational therapies. His current research grants include initiatives on cloud-based AI for neurological condition diagnosis, epilepsy precision care, and transcriptomics in SMC1A mutations.